In this video, Chris and Laycee discuss AbbVie's earnings report in early February and why the stock has moved into consolidation. They also touch on AbbVie's pipeline and the impact of patent expirations. Chris highlights the company's status as a Dividend King and why it could be a good investment option for investors.
Analyze this stock further with MarketBeat:
[ Ссылка ]
[ Ссылка ]
FREE 30 DAYS OF ALL ACCESS! Get started here: [ Ссылка ]
S U B S C R I B E
Want to see more from MarketBeat?
Hit that subscribe button!
#ABBV #abbvie #dividends #earningsreport #stockanalysis
